|
|
| |
| |
 |
|
|
 |
|
|
| |
FORMULATIONS
|
|
CAPS. 250 mg
D.S. CAPS. 500 mg
SUSP. (125mg/5ml) 60 ml
D.S. SUSP. (250mg/5ml) 60 ml
INJ. 250 mg
D.S. INJ. 500 mg
|
| INDICATIONS |
|
RTIs, UTIs/GIT Infections
Skin & Soft Tissue Infections
Post-operative Infections
|
Go
Back
|
|
|
|
|
| |
©
2006, CCL Pharmaceuticals |
|
